# IDE-ALERTS Continued Access Study

> **NCT04316481** · NA · TERMINATED · sponsor: **Angel Medical Systems** · enrollment: 17 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DEVICE:** AngelMed Guardian System

## Key facts

- **NCT ID:** NCT04316481
- **Lead sponsor:** Angel Medical Systems
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-09-22
- **Primary completion:** 2022-01-20
- **Final completion:** 2022-01-20
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** FDA Approval was received for the Model AMSG3-E IMD and therefore commercial implants could be started. There was no longer any need to implant under the CAS. CAS patients were transitioned to commercial patients.
- **Last updated:** 2022-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04316481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04316481, "IDE-ALERTS Continued Access Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04316481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*